Log In
Print
BCIQ
Print
Print this Print this
 

Champix, Chantix, varenicline

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSelective nicotinic acetylcholine receptor alpha(4)beta(2) partial agonist
Molecular Target Nicotinic acetylcholine receptor alpha(4)beta(2)
Mechanism of ActionNicotinic acetylcholine receptor alpha(4)beta(2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsSmoking cessation; Treat alcohol dependence; Treat smoking addiction in smokers with mild to moderate chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today